Your browser doesn't support javascript.
loading
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study.
van Vollenhoven, Ronald F; Hahn, Bevra H; Tsokos, George C; Wagner, Carrie L; Lipsky, Peter; Touma, Zahi; Werth, Victoria P; Gordon, Robert M; Zhou, Bei; Hsu, Benjamin; Chevrier, Marc; Triebel, Manon; Jordan, Jarrat L; Rose, Shawn.
Afiliação
  • van Vollenhoven RF; Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands; Free University (VU) Amsterdam, Amsterdam, Netherlands; Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands. Electronic address: r.vanvollenhoven@vumc.nl.
  • Hahn BH; University of California Los Angeles, Los Angeles, CA, USA.
  • Tsokos GC; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Wagner CL; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Lipsky P; AMPEL BioSolutions, LLC, Charlottesville, VA, USA.
  • Touma Z; University of Toronto, Toronto, ON, Canada.
  • Werth VP; Univeristy of Pennsylvania, Philadelphia, PA, USA; Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA, USA.
  • Gordon RM; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Zhou B; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Hsu B; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Chevrier M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Triebel M; Janssen Biologics BV, Leiden, Netherlands.
  • Jordan JL; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Rose S; Janssen Research & Development, LLC, Spring House, PA, USA.
Lancet ; 392(10155): 1330-1339, 2018 10 13.
Article em En | MEDLINE | ID: mdl-30249507
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ustekinumab / Lúpus Eritematoso Sistêmico / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ustekinumab / Lúpus Eritematoso Sistêmico / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article